Literature DB >> 6760859

Insulin mediates the stimulation of pyruvate kinase by a dual mechanism.

W C Parks, R L Drake.   

Abstract

A radioimmunoassay specific for liver pyruvate kinase was used to determine the mechanism(s) involved in the insulin stimulation of this enzyme activity in chronically diabetic rats. Rats, made diabetic with alloxan, were fed on a high-carbohydrate (50%-sucrose) fat-free diet and treated with insulin for 12, 36 or 60 h. Livers were removed at the various times, a piece was kept for determination of glycogen, and the remainder was homogenized. The 100000 g supernatant was prepared and used for determination of pyruvate kinase activity and quantity. Glycogen increased to a maximum of approx. 7% by 12 h after insulin treatment, and was maintained at this elevated value for 60 h. Liver pyruvate kinase activity, which is depressed in diabetes, did not respond to insulin until 36 h of treatment, with a more substantial increase occurring by 60 h. Radioimmunoassay data indicated that the increase in activity was concomitant with a substantial increase in the quantity of the enzyme and a moderate increase in its specific activity. These results demonstrate that a dual mechanism, i.e. an increase in both the quantity and specific activity of the enzyme, regulates the insulin-mediated stimulation of liver pyruvate kinase in the diabetic rat.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6760859      PMCID: PMC1153968          DOI: 10.1042/bj2080333

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  20 in total

1.  INSULIN: INDUCER OF PYRUVATE KINASE.

Authors:  G WEBER; N B STAMM; E A FISHER
Journal:  Science       Date:  1965-07-02       Impact factor: 47.728

2.  Rapid reciprocal changes in rat hepatic glycolytic enzyme and fructose diphosphatase activities following insulin and glucagon injection.

Authors:  O D Taunton; F B Stifel; H L Greene; R H Herman
Journal:  J Biol Chem       Date:  1974-11-25       Impact factor: 5.157

Review 3.  Drugs producing diabetes through damage of the insulin secreting cells.

Authors:  C C Rerup
Journal:  Pharmacol Rev       Date:  1970-12       Impact factor: 25.468

4.  A rapid enzymic method for glycogen estimation in very small tissue samples.

Authors:  F Huijing
Journal:  Clin Chim Acta       Date:  1970-12       Impact factor: 3.786

5.  Hepatic enzyme activities in streptozotocin-diabetic rats before and after insulin treatment.

Authors:  A Y Chang; D I Schneider
Journal:  Diabetes       Date:  1971-02       Impact factor: 9.461

6.  Glucagon-stimulated phosphorylation of pyruvate kinase in hepatocytes.

Authors:  H Ishibashi; G L Cottam
Journal:  J Biol Chem       Date:  1978-12-25       Impact factor: 5.157

7.  Evidence for a proteolytic modification of liver pyruvate kinase in fasted rats.

Authors:  E R Hall; V McCully; G L Cottam
Journal:  Arch Biochem Biophys       Date:  1979-07       Impact factor: 4.013

8.  Stimulation of glucagon of in vivo phosphorylation of rat hepatic pyruvate kinase.

Authors:  J P Riou; T H Claus; S J Pilkis
Journal:  J Biol Chem       Date:  1978-02-10       Impact factor: 5.157

9.  Modulation of the phosphorylation state of rat liver pyruvate kinase by allosteric effectors and insulin.

Authors:  T H Claus; M R El-Maghrabi; S J Pilkis
Journal:  J Biol Chem       Date:  1979-08-25       Impact factor: 5.157

10.  Rapid alterations induced by insulin in hepatocyte ultrastructure and glycogen levels.

Authors:  E W Thompson; W C Parks; R L Drake
Journal:  Am J Anat       Date:  1981-04
View more
  17 in total

1.  Effect of alloxan diabetes and subsequent insulin treatment on temperature kinetics properties of succinate oxidase activity in rat kidney mitochondria.

Authors:  Samir P Patel; Surendra S Katyare
Journal:  J Membr Biol       Date:  2007-03-08       Impact factor: 1.843

2.  Sparse linear discriminant analysis for simultaneous testing for the significance of a gene set/pathway and gene selection.

Authors:  Michael C Wu; Lingsong Zhang; Zhaoxi Wang; David C Christiani; Xihong Lin
Journal:  Bioinformatics       Date:  2009-01-25       Impact factor: 6.937

3.  Insulin-status-dependent modulation of FoF1-ATPase activity in rat liver mitochondria.

Authors:  Samir P Patel; Surendra S Katyare
Journal:  Lipids       Date:  2006-07       Impact factor: 1.880

4.  Starvation and feeding with a high-carbohydrate diet induce changes in the specific activity of rat hepatic pyruvate kinase.

Authors:  M A Cimbala; D Lau; J F Daigneault
Journal:  Biochem J       Date:  1985-02-15       Impact factor: 3.857

5.  Insulin-dependent changes in lysosomal cathepsin D activity in rat liver, kidney, brain and heart.

Authors:  M A Nerurkar; J G Satav; S S Katyare
Journal:  Diabetologia       Date:  1988-02       Impact factor: 10.122

6.  Artocarpus communis Forst. root-bark aqueous extract- and streptozotocin-induced ultrastructural and metabolic changes in hepatic tissues of Wistar rats.

Authors:  Stephen O Adewole; John A O Ojewole
Journal:  Afr J Tradit Complement Altern Med       Date:  2007-06-10

7.  Diabetic modulation of the temperature kinetics properties of cytochrome oxidase activity in rat brain mitochondria.

Authors:  Surendra S Katyare; Samir P Patel; Hiren R Modi
Journal:  Neurochem Res       Date:  2007-08-25       Impact factor: 3.996

8.  Diabetic cardiomyopathy and reactive oxygen species (ROS) related parameters in male and female rats: A comparative study.

Authors:  Vidya Akhileshwar; Samir P Patel; Surendra S Katyare
Journal:  Indian J Clin Biochem       Date:  2007-03

9.  Effect of streptozotocin-induced diabetes on oxidative energy metabolism in rat liver mitochondria-A comparative study of early and late effects.

Authors:  Jagannath G Satav; Surendra S Katyare
Journal:  Indian J Clin Biochem       Date:  2004-07

Review 10.  Insulin therapy for the management of hyperglycemia in hospitalized patients.

Authors:  Marie E McDonnell; Guillermo E Umpierrez
Journal:  Endocrinol Metab Clin North Am       Date:  2012-02-17       Impact factor: 4.741

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.